Molina Healthcare, Inc. (MOH - Free Report) recently announced that it will continue eliminating certain “out-of-pocket” expenses related to testing and treating COVID-19 through Dec 31, 2020. This initiative is for members covered under the company’s Medicare, Medicaid and Marketplace businesses.
Rationale Behind the Initiative
This strategic move aims to provide some respite to the members amid the coronavirus pandemic. Following the news of the fatal COVID-19 outbreak in the United States, Molina Healthcare had first removed specific ‘out-of-pocket’ costs required for COVID-19 testing in March.
Other Measures Taken
Molina Healthcare made other efforts as well, such as catering virtual health care services to Marketplace, Medicare and Medicaid members via its partnership with Teladoc Health, Inc. (TDOC - Free Report) . Along with containing the virus spread, such policies facilitate communication between homebound clients and their healthcare providers.
The company also reminds its members of easily accessing free home delivery of prescriptions through any CVS Pharmacy. It also covers screening tests for COVID-19 detection as well as monitor and implement telehealth coverage in compliance with the state Medicaid agency and CMS guidance.
Additionally, this leading health insurer offers its Coronavirus Chatbot tool to members who want information on COVID-19 risk factors. The same can be checked on the Molina Healthcare website, member portal and mobile app.
The way the company ramped up its endeavors to fight the coronavirus outbreak is quite commendable. Two of its industry peers, namely Anthem, Inc. and Cigna Corporation (CI - Free Report) also took initiatives to eradicate costs in relation to the COVID-19 treatment process.
Zacks Rank and Price Performance
Shares of this Zacks Rank #3 (Hold) company have rallied 26.6% year to date against the industry’s decline of 0.5%. We believe that the company’s solid fundamentals are likely to retain its existing momentum in the long run. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Molina Healthcare, Inc. (MOH - Free Report) recently announced that it will continue eliminating certain “out-of-pocket” expenses related to testing and treating COVID-19 through Dec 31, 2020. This initiative is for members covered under the company’s Medicare, Medicaid and Marketplace businesses.
Rationale Behind the Initiative
This strategic move aims to provide some respite to the members amid the coronavirus pandemic. Following the news of the fatal COVID-19 outbreak in the United States, Molina Healthcare had first removed specific ‘out-of-pocket’ costs required for COVID-19 testing in March.
Other Measures Taken
Molina Healthcare made other efforts as well, such as catering virtual health care services to Marketplace, Medicare and Medicaid members via its partnership with Teladoc Health, Inc. (TDOC - Free Report) . Along with containing the virus spread, such policies facilitate communication between homebound clients and their healthcare providers.
The company also reminds its members of easily accessing free home delivery of prescriptions through any CVS Pharmacy. It also covers screening tests for COVID-19 detection as well as monitor and implement telehealth coverage in compliance with the state Medicaid agency and CMS guidance.
Additionally, this leading health insurer offers its Coronavirus Chatbot tool to members who want information on COVID-19 risk factors. The same can be checked on the Molina Healthcare website, member portal and mobile app.
The way the company ramped up its endeavors to fight the coronavirus outbreak is quite commendable. Two of its industry peers, namely Anthem, Inc. and Cigna Corporation (CI - Free Report) also took initiatives to eradicate costs in relation to the COVID-19 treatment process.
Zacks Rank and Price Performance
Shares of this Zacks Rank #3 (Hold) company have rallied 26.6% year to date against the industry’s decline of 0.5%. We believe that the company’s solid fundamentals are likely to retain its existing momentum in the long run. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on MOH - FREE
Get the latest research report on CI - FREE
Get the latest research report on TDOC - FREE